| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 26445 | 2017 |
| Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 … B Zhou, RM Carrillo-Larco, G Danaei, LM Riley, CJ Paciorek, GA Stevens, ... The Lancet 398 (10304), 957-980, 2021 | 2627 | 2021 |
| World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions S Kaptoge, L Pennells, D De Bacquer, MT Cooney, M Kavousi, G Stevens, ... The Lancet global health 7 (10), e1332-e1345, 2019 | 970 | 2019 |
| Mendelian randomization of blood lipids for coronary heart disease MV Holmes, FW Asselbergs, TM Palmer, F Drenos, MB Lanktree, ... European heart journal 36 (9), 539-550, 2015 | 804 | 2015 |
| HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials DI Swerdlow, D Preiss, KB Kuchenbaecker, MV Holmes, JEL Engmann, ... The Lancet 385 (9965), 351-361, 2015 | 778 | 2015 |
| Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis JA López-López, JAC Sterne, HHZ Thom, JPT Higgins, AD Hingorani, ... bmj 359, 2017 | 606 | 2017 |
| Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials MV Holmes, P Newcombe, JA Hubacek, R Sofat, SL Ricketts, J Cooper, ... The Lancet 378 (9791), 584-594, 2011 | 431 | 2011 |
| Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based … A Rodriguez-Martinez, B Zhou, MK Sophiea, J Bentham, CJ Paciorek, ... The Lancet 396 (10261), 1511-1524, 2020 | 426 | 2020 |
| Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults NH Phelps, RK Singleton, B Zhou, RA Heap, A Mishra, JE Bennett, ... The Lancet 403 (10431), 1027-1050, 2024 | 404 | 2024 |
| Causal associations of adiposity and body fat distribution with coronary heart disease, stroke subtypes, and type 2 diabetes mellitus: a Mendelian randomization analysis CE Dale, G Fatemifar, TM Palmer, J White, D Prieto-Merino, D Zabaneh, ... Circulation 135 (24), 2373-2388, 2017 | 398 | 2017 |
| SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe European heart journal 42 (25), 2439-2454, 2021 | 373 | 2021 |
| Selecting instruments for Mendelian randomization in the wake of genome-wide association studies DI Swerdlow, KB Kuchenbaecker, S Shah, R Sofat, MV Holmes, J White, ... International journal of epidemiology 45 (5), 1600-1616, 2016 | 335 | 2016 |
| Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts T Shah, JP Casas, JA Cooper, I Tzoulaki, R Sofat, V McCormack, ... International journal of epidemiology 38 (1), 217-231, 2009 | 322 | 2009 |
| A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service V Kuan, S Denaxas, A Gonzalez-Izquierdo, K Direk, O Bhatti, S Husain, ... The Lancet Digital Health 1 (2), e63-e77, 2019 | 274 | 2019 |
| Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip PJ Talmud, F Drenos, S Shah, T Shah, J Palmen, C Verzilli, TR Gaunt, ... The American journal of human genetics 85 (5), 628-642, 2009 | 240 | 2009 |
| Repositioning of the global epicentre of non-optimal cholesterol Nature 582 (7810), 73-77, 2020 | 221 | 2020 |
| Genetic risk factors for intracranial aneurysms: a meta-analysis in more than 116,000 individuals VS Alg, R Sofat, H Houlden, DJ Werring Neurology 80 (23), 2154-2165, 2013 | 219 | 2013 |
| Improving the odds of drug development success through human genomics: modelling study AD Hingorani, V Kuan, C Finan, FA Kruger, A Gaulton, S Chopade, ... Scientific reports 9 (1), 18911, 2019 | 213 | 2019 |
| Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic … JAC Sterne, PN Bodalia, PA Bryden, PA Davies, JA López-López, ... Health Technology Assessment (Winchester, England) 21 (9), 1, 2017 | 187 | 2017 |
| Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis NJ Welton, A McAleenan, HHZ Thom, P Davies, W Hollingworth, ... Health technology assessment 21 (29), 2017 | 174 | 2017 |
